Oxford Sciences Innovation

Quick Facts

AUM

$500M

AUM Category

$100M-$500M

Headquarters

Oxford, UK

Founded

2015

Team Size

50-100

About Oxford Sciences Innovation

Oxford Sciences Innovation (OSI) is a private equity firm that specializes in the commercialization of scientific research emerging from the University of Oxford. OSI’s investment philosophy is centered on identifying and nurturing early-stage companies that have the potential to disrupt established markets through innovative technology. The firm typically engages in seed and Series A funding, providing not only capital but also strategic support to help portfolio companies scale their operations and accelerate their path to market. Their approach emphasizes long-term partnerships with founders and researchers, allowing for a collaborative environment that fosters innovation and growth. The firm has a strong focus on sectors that leverage advanced sciences, including biotechnology, pharmaceuticals, and medical devices. OSI actively seeks out companies that are developing pioneering solutions in health and life sciences, as well as technology platforms that can transform industries such as artificial intelligence and data analytics. By aligning their investment strategy with the cutting-edge research produced at Oxford, OSI aims to bridge the gap between academia and commercial viability, creating value through the translation of scientific discovery into tangible products and services. What sets OSI apart in the private equity landscape is its unique affiliation with the University of Oxford, which provides unparalleled access to a network of world-class researchers and a robust pipeline of innovative ideas. This connection not only enhances their deal flow but also contributes to their deep sector expertise, positioning them effectively to evaluate the scientific merit and market potential of prospective investments. Moreover, OSI’s commitment to building long-term relationships with its portfolio companies allows for a more hands-on approach to governance and operational support. For interim executives considering a partnership with OSI, it is important to recognize the firm’s collaborative ethos and commitment to scientific rigor. Executives should be prepared to engage deeply with the scientific and technical aspects of the businesses they will be supporting, as well as to contribute to shaping the strategic direction of these early-stage firms. Understanding the nuances of translating scientific innovation into commercial success will be critical in aligning with OSI’s objectives and maximizing the impact of their involvement.

Investment Focus

Sectors: Technology, Healthcare

Investment Stages: Venture, Growth

Portfolio Focus: DeepTech, HealthTech

Regional Offices

• London

Connect with Oxford Sciences Innovation

• Website

Frequently Asked Questions

Is Oxford Sciences Innovation a private equity firm?

Yes, Oxford Sciences Innovation is a private equity firm headquartered in Oxford, UK, founded in 2015.

What is Oxford Sciences Innovation's AUM (assets under management)?

Oxford Sciences Innovation manages approximately $500M in assets under management.

Where is Oxford Sciences Innovation headquartered?

Oxford Sciences Innovation is headquartered in Oxford, UK. Regional offices include London.

What sectors does Oxford Sciences Innovation invest in?

Oxford Sciences Innovation invests across Technology, Healthcare.

What investment stages does Oxford Sciences Innovation focus on?

Oxford Sciences Innovation focuses on Venture, Growth investments.

When was Oxford Sciences Innovation founded?

Oxford Sciences Innovation was founded in 2015.